• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吡啶斯的明诱发重症肌无力患者出现高度房室传导阻滞。

Pyridostigmine-induced high grade SA-block in a patient with myasthenia gravis.

作者信息

Said Sarmad, Cooper Chad J, Alkhateeb Haider, Elhanafi Sherif, Bizet Jorge, Gosavi Sucheta, Abedin Zainul

机构信息

Department of Internal Medicine, Paul L. Foster School of Medicine,Texas Tech University Health Sciences Center, El Paso, TX, U.S.A.

出版信息

Am J Case Rep. 2013 Sep 11;14:359-61. doi: 10.12659/AJCR.889484. eCollection 2013.

DOI:10.12659/AJCR.889484
PMID:24046803
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3775617/
Abstract

PATIENT

Female, 70 FINAL DIAGNOSIS: SA block induced by pyridostigmine Symptoms: Asymptomatic Medication: Pyridostigmine Clinical Procedure: Pacemaker insertion Specialty: Electrophysiology.

OBJECTIVE

Unusual clinical course.

BACKGROUND

Myasthenia gravis requires a long-term treatment with a parasympathomimetic agent, which may result in bradycardia and asystole. Pharmacologic treatment with a reversible inhibitor of inosine monophosphate dehydrogenase (IMPDH) and Methylprednisolone is seen to improve the muscular symptoms but may reinforce potential bradyarrhythmias. This potential side effect can be treated with the levo isomer of atropine, Hyoscyamine, or Glycopyrollate in an intact conduction system.

CASE REPORT

A 70-year old Caucasian female patient with a family history of myasthenia gravis presented with mild weakness of the bilateral facial muscles, moderate dysarthria, dysphagia, diplopia predominantly on the right side and difficulty tracking ocular movements bilaterally. The treatment with pharmacological agents was initiated. Subsequently she developed asymptomatic bradycardia and SA-block. An improvement on Hyoscyamine failed to appear. A dual chamber pacemaker was placed.

CONCLUSIONS

In symptomatic or asymptomatic bradycardia with significant high grade SA-block in patients with myasthenia gravis the insertion of a permanent pacemaker can be the definitive solution.

摘要

患者

女性,70岁 最终诊断:吡啶斯的明诱发的窦房阻滞 症状:无症状 用药:吡啶斯的明 临床操作:植入起搏器 专业:电生理学

目的

不寻常的临床病程

背景

重症肌无力需要使用拟副交感神经药物进行长期治疗,这可能导致心动过缓和心搏停止。使用肌苷单磷酸脱氢酶(IMPDH)可逆抑制剂和甲泼尼龙进行药物治疗可改善肌肉症状,但可能会加重潜在的缓慢性心律失常。在传导系统完整的情况下,这种潜在的副作用可用阿托品的左旋异构体、莨菪碱或格隆溴铵治疗。

病例报告

一名有重症肌无力家族史的70岁白人女性患者,出现双侧面部肌肉轻度无力、中度构音障碍、吞咽困难、主要为右侧的复视以及双侧眼球运动追踪困难。开始使用药物治疗。随后她出现无症状性心动过缓和窦房阻滞。使用莨菪碱后未见改善。植入了双腔起搏器。

结论

对于重症肌无力患者出现有症状或无症状的心动过缓且伴有严重高度窦房阻滞时,植入永久性起搏器可能是最终的解决办法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98e9/3775617/5e36adf9ec99/amjcaserep-14-359-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98e9/3775617/5e36adf9ec99/amjcaserep-14-359-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98e9/3775617/5e36adf9ec99/amjcaserep-14-359-g001.jpg

相似文献

1
Pyridostigmine-induced high grade SA-block in a patient with myasthenia gravis.吡啶斯的明诱发重症肌无力患者出现高度房室传导阻滞。
Am J Case Rep. 2013 Sep 11;14:359-61. doi: 10.12659/AJCR.889484. eCollection 2013.
2
Pyridostigmine Induced Prolonged Asystole in a Patient with Myasthenia Gravis Successfully Treated with Hyoscyamine.吡啶斯的明致重症肌无力患者长时间心搏停止,用莨菪碱成功治疗
Case Rep Cardiol. 2017;2017:6956298. doi: 10.1155/2017/6956298. Epub 2017 May 14.
3
Treatment of pyridostigmine-induced AV block with hyoscyamine in a patient with myasthenia gravis.用莨菪碱治疗重症肌无力患者中吡啶斯的明诱发的房室传导阻滞。
J Cardiovasc Electrophysiol. 2008 Feb;19(2):214-6. doi: 10.1111/j.1540-8167.2007.00938.x. Epub 2007 Aug 16.
4
[Asystole during electroconvulsive therapy in a patient with depression and myasthenia gravis].[一名患有抑郁症和重症肌无力的患者在接受电休克治疗期间出现心搏停止]
Masui. 2000 Aug;49(8):893-5.
5
The natural history and ophthalmic involvement in childhood myasthenia gravis at the hospital for sick children.病童医院中儿童重症肌无力的自然病史及眼部受累情况
Ophthalmology. 2000 Mar;107(3):504-10. doi: 10.1016/s0161-6420(99)00138-4.
6
7
Comparative effects of plasma exchange and pyridostigmine on respiratory muscle strength and breathing pattern in patients with myasthenia gravis.血浆置换与吡啶斯的明对重症肌无力患者呼吸肌力量和呼吸模式的比较性影响。
Thorax. 1995 Oct;50(10):1080-6. doi: 10.1136/thx.50.10.1080.
8
Fiberoptic endoscopic evaluation of swallowing with simultaneous Tensilon application in diagnosis and therapy of myasthenia gravis.在重症肌无力的诊断和治疗中,应用腾喜龙同时进行纤维内镜吞咽评估。
J Neurol. 2008 Feb;255(2):224-30. doi: 10.1007/s00415-008-0664-6. Epub 2008 Jan 28.
9
Unilateral-external Ophthalmoplegia: ARare Presentation of Myasthenia Gravis.单侧性眼外肌麻痹:重症肌无力的一种罕见表现
J Coll Physicians Surg Pak. 2016 Nov;26(11):142-143.
10
Third degree atrioventricular block and acquired myasthenia gravis in four dogs.四只犬的三度房室传导阻滞与获得性重症肌无力
J Am Vet Med Assoc. 1995 Apr 15;206(8):1173-6.

引用本文的文献

1
Pyridostigmine-induced complete atrioventricular block in a patient with Musk antibody-negative myasthenia gravis a case report : Pyridostigmine-ind advanced AV block in MG patient with MuSK-neg.吡啶斯的明诱发的完全性房室传导阻滞在一名肌肉特异性激酶(Musk)抗体阴性的重症肌无力患者中的病例报告:吡啶斯的明诱发重症肌无力患者(肌肉特异性激酶抗体阴性)出现进展性房室传导阻滞
BMC Cardiovasc Disord. 2025 Mar 27;25(1):225. doi: 10.1186/s12872-025-04681-0.
2
Pyridostigmine induced heart block requiring ICU admission.吡啶斯的明诱发心脏传导阻滞,需要入住重症监护病房。
J Community Hosp Intern Med Perspect. 2018 Oct 15;8(5):283-284. doi: 10.1080/20009666.2018.1527668. eCollection 2018.
3

本文引用的文献

1
Intravenous immunoglobulin for myasthenia gravis.静脉注射免疫球蛋白治疗重症肌无力
Cochrane Database Syst Rev. 2012 Dec 12;12(12):CD002277. doi: 10.1002/14651858.CD002277.pub4.
2
Evidence-based guideline: intravenous immunoglobulin in the treatment of neuromuscular disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.循证指南:静脉注射免疫球蛋白治疗神经肌肉疾病:美国神经病学学会治疗学和技术评估小组委员会的报告。
Neurology. 2012 Mar 27;78(13):1009-15. doi: 10.1212/WNL.0b013e31824de293.
3
The incidence of myasthenia gravis: a systematic literature review.
Pyridostigmine Induced Prolonged Asystole in a Patient with Myasthenia Gravis Successfully Treated with Hyoscyamine.
吡啶斯的明致重症肌无力患者长时间心搏停止,用莨菪碱成功治疗
Case Rep Cardiol. 2017;2017:6956298. doi: 10.1155/2017/6956298. Epub 2017 May 14.
重症肌无力发病率:系统文献回顾。
Neuroepidemiology. 2010;34(3):171-83. doi: 10.1159/000279334. Epub 2010 Feb 2.
4
Cardiac disease in myasthenia gravis: a literature review.
J Clin Neuromuscul Dis. 2003 Jun;4(4):199-203. doi: 10.1097/00131402-200306000-00006.
5
Treatment of pyridostigmine-induced AV block with hyoscyamine in a patient with myasthenia gravis.用莨菪碱治疗重症肌无力患者中吡啶斯的明诱发的房室传导阻滞。
J Cardiovasc Electrophysiol. 2008 Feb;19(2):214-6. doi: 10.1111/j.1540-8167.2007.00938.x. Epub 2007 Aug 16.
6
Myasthenia gravis: past, present, and future.重症肌无力:过去、现在与未来。
J Clin Invest. 2006 Nov;116(11):2843-54. doi: 10.1172/JCI29894.
7
Pericarditis in myasthenia gravis.重症肌无力伴发的心包炎
Cardiol Rev. 2004 May-Jun;12(3):134-7. doi: 10.1097/01.crd.0000117762.62596.8d.
8
Mycophenolate mofetil. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in renal transplantation.霉酚酸酯。其药效学、药代动力学特性及在肾移植中的临床疗效综述。
Drugs. 1996 Feb;51(2):278-98. doi: 10.2165/00003495-199651020-00007.